
Many clinical trials groups now routinely consider including Quality of Life zzso assessment in zzso Indeed, several have policies stating that zzso should be considered as a potential zzso in all new trials and that if it is not to be evaluated the applicants should justify not doing zzso However, inclusion of zzso in clinical trials presents a number of difficult zzso issues, and serious problems in compliance have frequently been zzso Thus, in zzso clinical trials many of the expected zzso questionnaires fail to be successfully completed and returned, although a few groups have claimed high success zzso However, it is well zzso that if questionnaires are missing, there may be bias in the interpretation of trial results, and the estimates of treatment differences and the overall level of zzso may be inaccurate and zzso Hence it is important to seek methods of improving compliance, at the level of both the participating institution and the zzso We describe a number of methods for addressing these issues, which we suggest should be considered by all those writing clinical trial protocols involving zzso zzso These are based upon over a decade of experience with assessing zzso in Medical Research Council zzso cancer clinical zzso In particular, we provide a checklist for points that should be covered in zzso Examples are given from a range of current zzso Cancer Trials Office zzso which it is proposed might act as templates when writing new zzso 

